Stanley M. Marks
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Papers in
- Genetics 13
- Chronic Lymphocytic Leukemia Research 11
-
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 4
- Co-authors
- Ronald P. McCaffrey (5 shared papers)David Baltimore (1 shared paper)Saša Živković (1 shared paper)Natalia L. Gonzalez (1 shared paper)Araya Puwanant (1 shared paper)Angela H. Lu (1 shared paper)Jarushka Naidoo (1 shared paper)Michael M. Boyiadzis (3 shared papers)
- Journals
- Blood (4 papers)Cancer (3 papers)Future Oncology (2 papers)American Journal of Hematology (2 papers)Journal of Oncology Practice (1 paper)
- Partner nations
- United StatesJapanFrance
In The Last Decade
Stanley M. Marks
28 papers receiving 870 citations
Peers
Comparison fields: 5 of 64
- Genetics 393
- Hematology 252
- Pathology and Forensic Medicine 303
- Oncology 232
- Immunology 175
Countries citing papers authored by Stanley M. Marks
This map shows the geographic impact of Stanley M. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stanley M. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stanley M. Marks more than expected).
Fields of papers citing papers by Stanley M. Marks
This network shows the impact of papers produced by Stanley M. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stanley M. Marks. The network helps show where Stanley M. Marks may publish in the future.
Co-authors
The 25 scholars most cited alongside Stanley M. Marks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1978 | 194 | |
| 2 | 2008 | 148 | |
| 3 | 2017 | 89 | |
| 4 | 2022 | 84 | |
| 5 | 2017 | 55 | |
| 6 | 2022 | 50 | |
| 7 | 2012 | 43 | |
| 8 | 1996 | 39 | |
| 9 | 1979 | 35 | |
| 10 | 2021 | 33 | |
| 11 | 1978 | 29 | |
| 12 | 2021 | 26 | |
| 13 | 1978 | 22 | |
| 14 | 2016 | 16 | |
| 15 | 2015 | 14 | |
| 16 | 1979 | 12 | |
| 17 | 1993 | 11 | |
| 18 | 2018 | 9 | |
| 19 | 2021 | 8 | |
| 20 | 2015 | 7 |
About Stanley M. Marks
Stanley M. Marks is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Rheumatology, having authored 28 papers that have together received 943 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (6 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Eosinophilic Disorders and Syndromes (3 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Viral-associated cancers and disorders (2 papers). The work is most often cited by research in Genetics (393 citations), Hematology (252 citations), Pathology and Forensic Medicine (303 citations), Oncology (232 citations) and Immunology (175 citations). Stanley M. Marks has collaborated with scholars based in United States, Japan and France. Frequent co-authors include Ronald P. McCaffrey, David Baltimore, Saša Živković, Natalia L. Gonzalez, Araya Puwanant, Angela H. Lu, Jarushka Naidoo, Michael M. Boyiadzis, Kenneth A. Foon and Ahmad A. Tarhini. Their work appears in journals such as Blood, Cancer, Future Oncology, American Journal of Hematology and Journal of Oncology Practice.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.